Uniqure NVNASDAQ:QURE
- LAST PRICE6.7800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots6.7200/ 3
- Ask / Lots7.1000/ 1
- Open / Previous Close6.8400 / 6.7800
- Day Range
- 52 Week Range
- Volume2,204,190
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QURE |
|---|---|---|
| 09:32 ET | 9754 | 6.84 |
| 09:33 ET | 1751 | 6.925 |
| 09:35 ET | 200 | 6.95 |
| 09:37 ET | 3648 | 6.91 |
| 09:39 ET | 800 | 6.925 |
| 09:42 ET | 3759 | 6.86 |
| 09:44 ET | 2037 | 6.9 |
| 09:46 ET | 1200 | 6.89 |
| 09:48 ET | 200 | 6.895 |
| 09:50 ET | 1217 | 6.91 |
| 09:51 ET | 400 | 6.87 |
| 09:53 ET | 721 | 6.85 |
| 09:55 ET | 2700 | 6.8573 |
| 09:57 ET | 7017 | 6.87 |
| 10:00 ET | 500 | 6.9 |
| 10:02 ET | 993 | 6.9086 |
| 10:04 ET | 1557 | 6.8889 |
| 10:06 ET | 1997 | 6.885 |
| 10:08 ET | 3799 | 6.865 |
| 10:09 ET | 1215 | 6.88 |
| 10:11 ET | 300 | 6.87 |
| 10:13 ET | 5265 | 6.88 |
| 10:18 ET | 100 | 6.84 |
| 10:20 ET | 3212 | 6.835 |
| 10:22 ET | 900 | 6.835 |
| 10:24 ET | 2871 | 6.855 |
| 10:26 ET | 2000 | 6.83 |
| 10:27 ET | 11031 | 6.88 |
| 10:29 ET | 3730 | 6.89 |
| 10:31 ET | 6975 | 6.91 |
| 10:33 ET | 5530 | 6.88 |
| 10:36 ET | 1786 | 6.865 |
| 10:38 ET | 1235 | 6.86 |
| 10:40 ET | 3941 | 6.84 |
| 10:42 ET | 1233 | 6.84 |
| 10:44 ET | 6528 | 6.76 |
| 10:45 ET | 7570 | 6.81 |
| 10:47 ET | 1000 | 6.795 |
| 10:49 ET | 1524 | 6.82 |
| 10:51 ET | 1391 | 6.84 |
| 10:54 ET | 5462 | 6.89 |
| 10:56 ET | 700 | 6.88 |
| 10:58 ET | 2473 | 6.89 |
| 11:00 ET | 2398 | 6.91 |
| 11:02 ET | 5994 | 6.895 |
| 11:03 ET | 9925 | 6.93 |
| 11:05 ET | 1716 | 6.93 |
| 11:07 ET | 8286 | 6.93 |
| 11:09 ET | 5919 | 6.88 |
| 11:12 ET | 1132 | 6.87 |
| 11:14 ET | 6861 | 6.845 |
| 11:16 ET | 1755 | 6.855 |
| 11:18 ET | 1840 | 6.845 |
| 11:20 ET | 500 | 6.83 |
| 11:21 ET | 3807 | 6.85 |
| 11:23 ET | 487 | 6.83 |
| 11:25 ET | 300 | 6.825 |
| 11:27 ET | 200 | 6.825 |
| 11:30 ET | 4072 | 6.77 |
| 11:32 ET | 2944 | 6.75 |
| 11:34 ET | 1500 | 6.74 |
| 11:36 ET | 7153 | 6.74 |
| 11:38 ET | 300 | 6.73 |
| 11:39 ET | 2966 | 6.74 |
| 11:41 ET | 29262 | 6.75 |
| 11:43 ET | 2564 | 6.775 |
| 11:45 ET | 383 | 6.8 |
| 11:48 ET | 2860 | 6.77 |
| 11:50 ET | 500 | 6.76 |
| 11:52 ET | 2906 | 6.765 |
| 11:54 ET | 200 | 6.77 |
| 11:56 ET | 2796 | 6.76 |
| 11:57 ET | 867 | 6.75 |
| 11:59 ET | 1595 | 6.75 |
| 12:01 ET | 1100 | 6.75 |
| 12:03 ET | 1791 | 6.755 |
| 12:06 ET | 300 | 6.77 |
| 12:08 ET | 1125 | 6.766 |
| 12:10 ET | 2161 | 6.79 |
| 12:12 ET | 1406 | 6.78 |
| 12:14 ET | 1002 | 6.78 |
| 12:15 ET | 3299 | 6.79 |
| 12:17 ET | 300 | 6.79 |
| 12:19 ET | 800 | 6.775 |
| 12:21 ET | 1100 | 6.76 |
| 12:24 ET | 5690 | 6.74 |
| 12:26 ET | 3039 | 6.74 |
| 12:28 ET | 500 | 6.745 |
| 12:30 ET | 2660 | 6.745 |
| 12:32 ET | 1813 | 6.755 |
| 12:33 ET | 200 | 6.76 |
| 12:35 ET | 1610 | 6.755 |
| 12:37 ET | 200 | 6.76 |
| 12:39 ET | 1100 | 6.76 |
| 12:42 ET | 400 | 6.77 |
| 12:44 ET | 2830 | 6.77 |
| 12:46 ET | 500 | 6.78 |
| 12:48 ET | 2349 | 6.78 |
| 12:50 ET | 24665 | 6.8 |
| 12:51 ET | 2075 | 6.83 |
| 12:53 ET | 2969 | 6.8484 |
| 12:55 ET | 2917 | 6.855 |
| 12:57 ET | 1800 | 6.87 |
| 01:00 ET | 508 | 6.88 |
| 01:02 ET | 900 | 6.87 |
| 01:04 ET | 1531 | 6.9 |
| 01:06 ET | 1416 | 6.9 |
| 01:08 ET | 3019 | 6.875 |
| 01:09 ET | 2765 | 6.87 |
| 01:11 ET | 500 | 6.865 |
| 01:13 ET | 300 | 6.87 |
| 01:15 ET | 1100 | 6.87 |
| 01:18 ET | 300 | 6.88 |
| 01:20 ET | 3009 | 6.91 |
| 01:22 ET | 1189 | 6.91 |
| 01:24 ET | 500 | 6.915 |
| 01:26 ET | 700 | 6.915 |
| 01:27 ET | 6142 | 6.91 |
| 01:31 ET | 3157 | 6.885 |
| 01:33 ET | 1606 | 6.875 |
| 01:36 ET | 3837 | 6.89 |
| 01:38 ET | 100 | 6.895 |
| 01:40 ET | 1000 | 6.885 |
| 01:42 ET | 3720 | 6.925 |
| 01:44 ET | 1400 | 6.92 |
| 01:45 ET | 700 | 6.92 |
| 01:47 ET | 900 | 6.925 |
| 01:49 ET | 3770 | 6.905 |
| 01:51 ET | 1419 | 6.92 |
| 01:54 ET | 3222 | 6.905 |
| 01:56 ET | 1639 | 6.905 |
| 01:58 ET | 800 | 6.905 |
| 02:00 ET | 1600 | 6.905 |
| 02:02 ET | 5800 | 6.895 |
| 02:03 ET | 2541 | 6.905 |
| 02:05 ET | 4000 | 6.915 |
| 02:07 ET | 2943 | 6.915 |
| 02:09 ET | 500 | 6.9175 |
| 02:12 ET | 4305 | 6.915 |
| 02:14 ET | 3300 | 6.9175 |
| 02:16 ET | 1444 | 6.915 |
| 02:18 ET | 4600 | 6.915 |
| 02:20 ET | 900 | 6.915 |
| 02:21 ET | 22208 | 6.89 |
| 02:23 ET | 2372 | 6.89 |
| 02:25 ET | 3139 | 6.885 |
| 02:27 ET | 1701 | 6.89 |
| 02:30 ET | 1526 | 6.89 |
| 02:32 ET | 6424 | 6.89 |
| 02:34 ET | 600 | 6.88 |
| 02:36 ET | 1710 | 6.87 |
| 02:38 ET | 1371 | 6.875 |
| 02:39 ET | 2619 | 6.875 |
| 02:41 ET | 500 | 6.88 |
| 02:43 ET | 300 | 6.885 |
| 02:45 ET | 1473 | 6.88 |
| 02:48 ET | 4544 | 6.85 |
| 02:50 ET | 600 | 6.85 |
| 02:52 ET | 1100 | 6.85 |
| 02:54 ET | 4079 | 6.865 |
| 02:56 ET | 200 | 6.87 |
| 02:59 ET | 1500 | 6.87 |
| 03:01 ET | 2917 | 6.85 |
| 03:03 ET | 100 | 6.85 |
| 03:06 ET | 4501 | 6.835 |
| 03:08 ET | 2458 | 6.82 |
| 03:10 ET | 100 | 6.82 |
| 03:12 ET | 3979 | 6.79 |
| 03:14 ET | 1502 | 6.8 |
| 03:15 ET | 1498 | 6.79 |
| 03:17 ET | 3139 | 6.78 |
| 03:19 ET | 4303 | 6.795 |
| 03:21 ET | 1086 | 6.81 |
| 03:24 ET | 1900 | 6.805 |
| 03:26 ET | 4100 | 6.805 |
| 03:28 ET | 6844 | 6.815 |
| 03:30 ET | 6356 | 6.855 |
| 03:32 ET | 5168 | 6.85 |
| 03:33 ET | 3806 | 6.835 |
| 03:35 ET | 10582 | 6.815 |
| 03:37 ET | 33831 | 6.8 |
| 03:39 ET | 3519 | 6.79 |
| 03:42 ET | 2327 | 6.805 |
| 03:44 ET | 35222 | 6.8 |
| 03:46 ET | 42765 | 6.815 |
| 03:48 ET | 20588 | 6.77 |
| 03:50 ET | 4174 | 6.78 |
| 03:51 ET | 9294 | 6.765 |
| 03:53 ET | 11499 | 6.77 |
| 03:55 ET | 28264 | 6.775 |
| 03:57 ET | 23158 | 6.8 |
| 04:00 ET | 728609 | 6.78 |
Nov 29, 2023
uniQure Announces FDA Clearance of Investigational New Drug Application forAMT-191 Gene Therapy for Fabry Disease, from 7:05AM ET on Wednesday Nov 29, 2023 by Dow Jones
7:05AM ET on Wednesday Nov 29, 2023 by Dow JonesuniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease, from 7:05AM ET on Wednesday Nov 29, 2023 by Dow Jones
7:05AM ET on Wednesday Nov 29, 2023 by Dow Jones
Nov 8, 2023
DJ uniQure Is Maintained at Buy by Goldman Sachs, from 8:51AM ET on Wednesday Nov 08, 2023 by Dow Jones
8:51AM ET on Wednesday Nov 08, 2023 by Dow Jones
Nov 7, 2023
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress, from 7:05AM ET on Tuesday Nov 07, 2023 by Dow Jones
7:05AM ET on Tuesday Nov 07, 2023 by Dow JonesuniQure Announces Third Quarter 2023 Financial Resultsand Highlights Recent Company Progress, from 7:05AM ET on Tuesday Nov 07, 2023 by Dow Jones
7:05AM ET on Tuesday Nov 07, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Uniqure NV | 325.1M | -1.4x | --- |
Xeris Biopharma Holdings Inc | 254.8M | -4.1x | --- |
Agenus Inc | 267.3M | -1.0x | --- |
Fate Therapeutics Inc | 258.3M | -1.4x | --- |
Heron Therapeutics Inc | 195.1M | -1.3x | --- |
Kamada Ltd | 274.2M | 38.8x | --- |
Company Information
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Contact Information
- Headquarters
- Paasheuvelweg 25aAMSTERDAM, Netherlands 1105 BP
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- David Meek
- Chief Executive Officer, Executive Director
- Matthew Kapusta
- Chief Financial Officer
- Christian Klemt
- Chief Operations Officer
- Pierre Caloz
- Chief Business and Scientific Officer
- Ricardo Dolmetsch
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $325.1M |
|---|---|
Revenue (TTM) | $111.9M |
Shares Outstanding | 47.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.02 |
EPS | $-4.79 |
Book Value | $10.13 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 2.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -173.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
